Sanofi cuts supply of influenza vaccines to Ukraine by 60% in current epidemic season

The pharmaceutical company Sanofi reduced the supply of influenza vaccines to Ukraine by 60% in the current epidemic season - it delivered 100,000 doses, additional deliveries are not planned.

As the pharmaceutical company told Interfax-Ukraine, in the last epidemic season it delivered 250,000 doses to Ukraine.

"The reduction in flu vaccine supplies produced by Sanofi this season is due to temporary production process difficulties, including the company's global transition to producing a trivalent vaccine in accordance with updated WHO recommendations. Currently, the company is adapting technological and logistical processes, which has temporarily affected the volume of vaccine supplies to countries in the Northern Hemisphere, particularly Ukraine. Additional supplies of the vaccine are not expected this year," the company reported.

In addition, the company reported that the only quadrivalent influenza vaccine registered by the Ministry of Health for the 2025/2026 epidemic season from Sanofi in Ukraine is the quadrivalent influenza vaccine, which was imported in the amount of 100,000 doses.

Currently, the media and social networks are reporting a significant shortage of influenza vaccines in the current epidemic season. Private clinics report the inability to purchase the vaccine.

Interfax-Ukraine is awaiting a comment on the situation with vaccines in the current epidemic season from the Ministry of Health, the SEC and the State Service of Ukraine on Medicines and Drugs Control.